A dot blot hybridization protocol was developed for the direct detection of molluscum contagiosum virus (MCV) DNA in clinical specimens submitted for virus isolation. Samples were concentrated by high-speed centrifugation and treated with proteinase K; this was followed by a single phenol-chloroform extraction step. The DNA was denatured, and the entire volume was spotted onto a nitrocellulose membrane. A biotinylated DNA probe specific for the BamHI-C region of MCV type 1 was used for hybridization. Evidence of MCV DNA was visualized by using streptavidin alkaline phosphatase conjugate and 5-bromo-4-chloro-3-indolyl phosphate-nitroblue tetrazolium as the substrate. Results showed that nonspecific hybridization does not occur with herpes simplex virus-or orf virus-infected clinical specimens and that dot blotting is more sensitive and reproducible than electron microscopy.
Molluscum contagiosum virus (MCV) infection is generally a self-limiting benign disease that produces single or multiple lesions on most skin areas. The disease has a worldwide distribution, and most healthy humans are susceptible (16) . Although the lesions usually resolve spontaneously, aberrant forms have been described, especially in association with immunocompromised patients such as those with AIDS (2, 9, 16) .
Since a differential diagnosis is often necessary to exclude other malignant and nonmalignant diseases, skin scrapings, swabs, or both are commonly submitted to the laboratory for virus isolation studies (2, 14, 15, 18) . It is in the clinical virology laboratory that MCV presents a unique challenge to the microbiologist. On the one hand, the lesions are often pathognomonic to the attending physician. If some doubt exists, then formalin-fixed lesions can be embedded in paraffin, sectioned, and examined by histological or immunohistochemical methods (13) . A characteristic cytopathology, consisting of giant cells, each with a large intracytoplasmic hyaline acidophilic granular mass known as a molluscum body, is usually present and is easily identified by the pathologist or cytotechnologist (6) . On the other hand, this organism cannot be definitively identified in the virus laboratory by standard methods because, at present, MCV cannot be propagated in any known cell line. It does produce an abortive infection in vitro with slight cytopathic effects in some cell lines (16) . However, it does not produce infectious progeny (10) . Therefore, routine immunohistochemical methods have been unsuccessful in the identification of MCV in cell culture.
As a member of the Poxviridae family, this organism produces large numbers of characteristic poxlike virions in the skin lesion (17) , and this has facilitated their presumptive identification by electron microscopy (EM The specimens used in this study were (i) culture negative for herpesvirus but showed cytopathic effects resembling that of MCV or (ii) from patients whose clinical symptoms were suggestive of MCV. A portion of each specimen was tested by EM for the presence of virus particles. Our standard EM procedure has been described previously (11) . Nonspecific controls consisted of clinical specimens that were confirmed by culture or EM to be infected with herpes simplex virus type 1 or 2 or orf virus.
DNA biotinylated probe. The 13.5-kb BamHI-C fragment of the MCV type 1 (MCV-1) genome was ligated into the 3.6-kb pAT153 plasmid vector (3, 21 This entire volume (approximately 0.5 ml) was then spotted onto an Immobilon-NC nitrocellulose membrane (Millipore Corp., Bedford, Mass.), which was presoaked in 1 M ammonium acetate, using a vacuum apparatus (Bethesda Research Laboratory, Gaithersburg, Md.). After rinsing briefly in 1 M ammonium acetate, the membrane was airdried and baked for 1 to 2 h under vacuum at 80°C (8) . Positive and negative controls were made by spotting known amounts of pMCV-1-B-C and salmon sperm DNA, respectively. Each control was subjected to alkaline denaturation before use, as described above.
Positive and negative control spots consisting of 50 ng of pMCV-1-B-C DNA and 500 ng of salmon sperm DNA, respectively, were denatured as described above and were included in every dot blot run.
Hybridization. Membranes were prehybridized in a solution (final concentrations are given) of 50% deionized formamide, 5 x SSC (750 mM sodium chloride, 75 mM sodium citrate), Sx Denhardt solution (0.1% Ficoll, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin), 25 mM sodium phosphate buffer (pH 6.5), 0.5% SDS, and 0.5 mg of denatured salmon sperm DNA per ml at 43°C for 3 to 4 h. These membranes were then hybridized overnight at 43°C in a probe solution (final concentrations are given) of 47% deionized formamide, 5x SSC, 5% dextran sulfate, lx Denhardt solution, 20 mM sodium phosphate buffer (pH 6.5), 0.1% SDS, 0.2 mg of denatured salmon sperm DNA per ml, and 200 to 300 ng of denatured biotinylated probe per ml. The optimal probe concentration was previously determined by titration. DNA was denatured by heating it in boiling water for 10 min (7).
Each membrane was washed twice at room temperature in 2x SSC with 0.1% SDS for 5 min each time, twice in 0.2x SSC with 0.1% SDS for 5 min each time, and twice in 0.16x SSC with 0.1% SDS at 55 to 60°C for 15 min each time. After a brief rinse in 0.2x SSC, they were soaked in blocking buffer (1 x phosphate-buffered saline, 3% bovine serum albumin, 0.05% Triton X-100, 5 mM EDTA) at 36°C for 30 min. They were then reacted with streptavidin conjugated with alkaline phosphatase (DETEK-1-alk; ENZO Diagnostics) by following the instructions of the manufacturer. This was followed by five room-temperature washing steps in buffer (10 mM potassium phosphate buffer [pH 5.5], 0.5 M NaCl, 0.5% Triton X-100, 1 mM EDTA, 2% bovine serum albumin) for 5 color.
RESULTS
The probe sensitivity limit was determined by multiple testing of different lots of probe. Each was hybridized with known amounts of pMCV-1-B-C DNA. As illustrated in Fig.  1 , the endpoint was approximately 5 pg in every test. At this concentration the color was faintly visible. On the basis of the relative sizes of the plasmid vector and its insert, nearly 74% of the total DNA in each spot was BamHI-C. Therefore, the actual sensitivity limit of our probe with MCV DNA extracted from clinical samples was probably 7 to 10 pg. The negative control spot was included to ensure probe specificity. Figure 2 shows the results of the probe specificity tests by using clinical specimens with confirmed herpes simplex virus or orf virus infections. Nonspecific hybridization did not occur with any of these samples. The negative and positive controls were included to further ensure the specificity and sensitivity of our probe.
Several comparative studies were done by using clinical specimens previously tested by EM to evaluate the detectability of the dot blot hybridization probe. Dot blots generally paralleled the EM results. Figure 3 is testing is equivalent to about 200 pg of genomic DNA per sample. Thus, the weakly reactive dot blots from EMnegative specimens are most likely true positives and reflect a relatively low number of virus particles in the clinical sample. During the course of this study, multiple EM tests were occasionally required on a single specimen to establish the presence of poxlike particles, whereas these same specimens always produced a strong positive dot blot.
The overall sensitivity of this procedure is a function of both probe sensitivity and methodology. Therefore, a protocol was designed to maximize viral DNA recovery by working with minimum volumes in the fewest possible steps. Thus, the initial centrifugation, proteinase K treatment, and DNA extraction steps were all carried out in the same microcentrifuge tube. Likewise, the final alkaline denaturation and neutralization steps were done in a single tube. 
